NO20051696L - Preparat for behandling av gastrointestinale lidelser - Google Patents

Preparat for behandling av gastrointestinale lidelser

Info

Publication number
NO20051696L
NO20051696L NO20051696A NO20051696A NO20051696L NO 20051696 L NO20051696 L NO 20051696L NO 20051696 A NO20051696 A NO 20051696A NO 20051696 A NO20051696 A NO 20051696A NO 20051696 L NO20051696 L NO 20051696L
Authority
NO
Norway
Prior art keywords
preparation
weight
treatment
gastrointestinal disorders
disorder
Prior art date
Application number
NO20051696A
Other languages
English (en)
Other versions
NO335232B1 (no
Inventor
Nicolai Agger
Original Assignee
Pharmalett As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalett As filed Critical Pharmalett As
Publication of NO20051696L publication Critical patent/NO20051696L/no
Publication of NO335232B1 publication Critical patent/NO335232B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Abstract

Det beskrives et preparat omfattende 5-50 vektprosent Isphagula Husk; 1-20 vektprosent av minst én aminosyre; 20-80 vektprosent av minst ett karbohydrat samt elektrolytter. Preparatet finner anvendelse som terapeutisk middel, særlig for behandling av en lidelsestilstand i intestinalsystemet hos monogastriske dyr, inkludert mennesker. En lidelsestilstand i intestinalsystemet er særlig alle intestinallidelser der epitelsjiktet skades, som regel som et resultat av malabsorpsjonsdiaré, også forbundet med dehydratisering.
NO20051696A 2002-11-11 2005-04-06 Preparat omfattende Isphagula Husk for anvendelse som et terapeutisk middel ved behandling av en lidelsestilstand i intestinalsystemet hos monogastriske dyr, inkludert mennesker NO335232B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK200201736A DK175877B1 (da) 2002-11-11 2002-11-11 Præparater til anvendelse som terapeutisk middel
PCT/DK2003/000773 WO2004043451A1 (en) 2002-11-11 2003-11-11 Composition for the treatment of gastrointestinal disorders

Publications (2)

Publication Number Publication Date
NO20051696L true NO20051696L (no) 2005-05-23
NO335232B1 NO335232B1 (no) 2014-10-27

Family

ID=32309261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051696A NO335232B1 (no) 2002-11-11 2005-04-06 Preparat omfattende Isphagula Husk for anvendelse som et terapeutisk middel ved behandling av en lidelsestilstand i intestinalsystemet hos monogastriske dyr, inkludert mennesker

Country Status (14)

Country Link
US (1) US20060068039A1 (no)
EP (1) EP1572182B1 (no)
JP (1) JP2006511504A (no)
AT (1) ATE353011T1 (no)
AU (1) AU2003280314A1 (no)
CA (1) CA2500398C (no)
DE (1) DE60311595T2 (no)
DK (2) DK175877B1 (no)
ES (1) ES2281669T3 (no)
MX (1) MXPA05004994A (no)
NO (1) NO335232B1 (no)
PT (1) PT1572182E (no)
SI (1) SI1572182T1 (no)
WO (1) WO2004043451A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008105983A1 (en) * 2007-02-27 2008-09-04 Albion International, Inc. Mineral absorption from the stomach
US9420807B2 (en) 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
BR112013006044B1 (pt) 2010-09-24 2022-03-29 University Of Florida Research Foundation, Inc Composição terapêutica para administração enteral compreendendo como aminoácidos livres, serina e valina, bem como embalagem contendo a dita composição
BR112014019350B1 (pt) * 2012-02-08 2020-09-24 University Of Florida Research Foundation, Inc. Composição terapêutica estéril, seu uso para tratar diarreia induzida por rotavírus e embalagem
ITRM20120084A1 (it) * 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
CA2904046C (en) 2013-03-11 2020-01-14 University Of Florida Research Foundation, Incorporated Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
WO2016199798A1 (ja) * 2015-06-10 2016-12-15 味の素株式会社 運動誘発性の消化管障害の改善剤
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
KR102463684B1 (ko) * 2021-05-12 2022-11-04 우진 비앤지 주식회사 전해질, 비타민, 아미노산 및 당류를 포함하는 동물의 탈수 예방 또는 개선용 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449492A (en) * 1964-10-05 1969-06-10 Upjohn Co Water reconstitutable kaolin-pectin powders
US3898328A (en) * 1973-12-03 1975-08-05 Syntex Inc Dry stable composition for the treatment of scours and dehydration
US3989328A (en) * 1975-05-02 1976-11-02 Whirlpool Corporation Refrigerator cabinet construction
NZ183492A (en) * 1976-03-27 1980-04-28 Beecham Group Ltd Veterinary rehydration compositions containing monosaccharide amino acid and citric acid or citrate
DK149941C (da) * 1981-02-10 1987-05-18 Magius N W Von Fodertilskudsmiddel med vaekstfremmende virkning
DK454683D0 (da) * 1983-10-03 1983-10-03 Mogens Gjerloev Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf
US5038396A (en) * 1983-10-03 1991-08-06 Mogens Gjerlov Preparation for rehydrating monogastric animals, including new-born calves, pigs and human beings suffering from diarrhoea and use thereof
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4839171A (en) * 1984-11-30 1989-06-13 Techmix, Inc. Composition for treating impaired lactation
GB8528307D0 (en) * 1985-11-18 1985-12-24 Beecham Group Plc Veterinary compositions
CA2009168A1 (en) * 1989-02-07 1990-08-07 Herman Derk Louwes Effervescent composition for oral rehydration
JPH04224521A (ja) * 1990-12-18 1992-08-13 Guerurebu Mogens 下痢症を有する一つの胃の動物、たとえば新生ウシ、ブタ及びヒトを再水和化するための製剤及びその使用
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
JPH09510461A (ja) * 1994-03-24 1997-10-21 ベーリンガー インゲルハイム アグロベット アー／エス 薬剤又は栄養剤を動物に投与するための粒状生成物を含む投薬ユニット及び粒状生成物の製造方法
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6066341A (en) * 1999-03-15 2000-05-23 Farnam Companies, Inc. Composition for the treatment of scours in calves
JP2002020300A (ja) * 2000-07-07 2002-01-23 Ichimaru Pharcos Co Ltd 化粧料組成物
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
JP2002226369A (ja) * 2001-01-30 2002-08-14 Otsuka Pharmaceut Co Ltd グルタミン含有経口組成物

Also Published As

Publication number Publication date
DK175877B1 (da) 2005-05-09
DK200201736A (da) 2004-05-12
SI1572182T1 (sl) 2007-06-30
EP1572182B1 (en) 2007-01-31
CA2500398A1 (en) 2004-05-27
DE60311595D1 (de) 2007-03-22
ES2281669T3 (es) 2007-10-01
MXPA05004994A (es) 2005-11-23
WO2004043451A1 (en) 2004-05-27
US20060068039A1 (en) 2006-03-30
CA2500398C (en) 2012-01-24
NO335232B1 (no) 2014-10-27
DE60311595T2 (de) 2007-11-15
AU2003280314A1 (en) 2004-06-03
JP2006511504A (ja) 2006-04-06
EP1572182A1 (en) 2005-09-14
ATE353011T1 (de) 2007-02-15
PT1572182E (pt) 2007-04-30
DK1572182T3 (da) 2007-05-07

Similar Documents

Publication Publication Date Title
NO20051696L (no) Preparat for behandling av gastrointestinale lidelser
FR2819723B1 (fr) Composition halogene, son procede de preparation et ses utilisations
WO2007070547A3 (en) Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
WO2004098589A8 (en) 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
WO2004017920A3 (en) Novel biphenyl and biphenyl-like cannabinoids
BRPI0407454A (pt) Pirazóis e métodos de preparar e usar os mesmos
WO2009067639A3 (en) Variants of c-type natriuretic peptide
EA200900211A1 (ru) Замещенные производные имидазолона, их получение и применение
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
NO20075354L (no) Forbindelser, isomerer og farmasoytiske akseptable salter derav, som vanilloidreseptorantagoniser, og farmasoytiske preparater inneholdende slike
DK1709161T3 (da) Humane terapeutiske celler, som udskiller nervevækstfaktor
BR0313983A (pt) Composto compreendendo extrato de actinida arguta e espécies afins para a prevenção e tratamento de doenças alérgicas e doenças inflamatórias não alérgicas
ATE400278T1 (de) Immunmodulierende oligosaccharide
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
WO2005007652A3 (en) Substituted quinolin-4-ylamine analogues
WO2004074243A3 (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
EA200401341A1 (ru) Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
WO2007135026A3 (de) Substituierte pteridine als therapeutika
WO2004013287A3 (en) Antibodies against c3a receptor
WO2008033739A3 (en) Benzimidazole carboxamide derivatives
BR0314783A (pt) Pirróis 3,4-dissubstituìdos e seu uso no tratamento de doenças inflamatórias
ATE267816T1 (de) Tan-1057 derivate
WO2007076319A3 (en) Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
WO2008075333A3 (en) Edible compositions for preventing hair loss

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees